đź“‹ FDA Reference
vascular access port cath cat vp-xxxx vasport ser
Gish Biomedical
Summary: The vascular access port cath cat vp-xxxx is a medical device used for long-term venous access, commonly utilized in chemotherapy or other intravenous treatments. It is typically used by oncologists and other specialists managing chronic conditions requiring frequent venous access.
FDA Clearance Information
Pathway
510K
Number
K854610 ↗
Decision Date
May 8, 1986
Product Code
DQY
Device Class
Class 2
Evidence
0 studies
The vascular access port cath cat vp-xxxx by Gish Biomedical was cleared via the FDA 510k pathway on May 8, 1986. It is classified as a Class 2 device under the product code DQY.
What It Is
This device is a vascular access port, which is a small medical appliance installed beneath the skin. It connects to a catheter that enters a vein, allowing easy access for intravenous treatments. The port is designed to facilitate repeated access to the venous system, reducing the need for multiple needle sticks and providing a reliable means for drug delivery or blood sampling.
Clinical Applications
Vascular access ports are commonly used in oncology for patients undergoing chemotherapy, as they require frequent and reliable venous access. They are also used in hematology for patients with chronic conditions like lymphoma or leukemia. These devices are typically placed in a hospital or outpatient surgical setting by a surgeon or interventional radiologist.
Indications for Use
The device is indicated for patients who need long-term intravenous therapy, such as those undergoing chemotherapy or requiring frequent blood transfusions. It is suitable for patients with conditions like chronic myelomonocytic leukemia or other hematologic disorders.
Practical Considerations
Vascular access ports come in various sizes to accommodate different patient needs and are compatible with standard infusion systems. Placement requires a minor surgical procedure, and care should be taken to maintain sterility during access to prevent infections.
Related Literature
The linked study explored the use of ascorbic acid in conjunction with chemotherapy for treating relapsed or refractory lymphoma, CCUS, and chronic myelomonocytic leukemia. While the study abstract is not available, it likely investigated the efficacy and safety of this combination therapy. Limitations may include a lack of detailed results and potential small sample size.
Frequently Asked Questions
What is the vascular access port cath cat vp-xxxx used for?
It is used for providing long-term venous access for patients requiring frequent intravenous treatments, such as chemotherapy.
What specialties typically use this device?
Oncology and hematology specialists commonly use this device for managing patients with cancer or chronic blood disorders.
What are the FDA-cleared indications?
The device is indicated for patients needing long-term intravenous therapy, such as those undergoing chemotherapy or frequent blood transfusions.
Disclaimer: This page compiles publicly available regulatory and published clinical evidence for educational reference.
It does not constitute medical advice, product endorsement, or a recommendation for clinical use.
Always consult manufacturer documentation and clinical judgment for patient care decisions.